How can it be a friggin lie @Starlink if it’s written in black and white in Starpharma’s own ASX announcement? Surely you actually read the announcement.
‘Viraleze™ reduced viral load in the full study population including all patient age groups (N=197), although the difference vs placebo was not statistically significant’
Whereas you are highlighting a cherry picked subset of the trial participants. How did the trial go when considering all of the patient population? I’ll tell you how it went. The trial failed.
The question is, does excessive pomegranate consumption affect one’s ability to comprehend?
Ann: Viraleze shows antiviral efficacy in COVID-19 patients, page-60
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.29M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 10.0¢ | $12.03K | 116.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 109616 | 3 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |